Aileron Therapeutics Inc ALRN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/27/24 EDT
6.93quote price arrow up+1.23 (+21.60%)
Volume
159,161
52 week range
1.01 - 7.12
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.93
  • 52 Week High7.12
  • 52 Week High Date03/27/24
  • 52 Week Low1.01
  • 52 Week Low Date10/31/23

Key Stats

  • Market Cap33.861M
  • Shares Out4.89M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.18
  • YTD % Change127.35

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.93
  • 52 Week High7.12
  • 52 Week High Date03/27/24
  • 52 Week Low1.01
  • 52 Week Low Date10/31/23
  • Market Cap33.861M
  • Shares Out4.89M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta2.18
  • YTD % Change127.35

RATIOS/PROFITABILITY

  • EPS (TTM)-2.85
  • P/E (TTM)-2.43
  • Fwd P/E (NTM)-9.32
  • EBITDA (TTM)-12.639M
  • ROE (TTM)-76.36%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aileron Therapeutics Inc

 

Profile

MORE
Aileron Therapeutics, Inc. is a biopharmaceutical company. The Company is advancing a pipeline of medicines to address unmet medical needs in orphan pulmonary and fibrosis indications. Its lead product candidate, LTI-03, is a synthetic peptide with a dual mechanism targeting alveolar epithelial cell survival as well as inhibition of profibrotic signaling. LTI-03 is being evaluated in a Phase Ib clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its...
Josef von Rickenbach
Independent Chairman of the Board
Brian Windsor Ph.D.
President, Chief Executive Officer, Director
Susan Drexler CPA
Interim Chief Financial Officer
Address
738 Main Street, Unit 398
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
INKT
Mink Therapeutics Inc
0.91-0.028-2.9851%
ACXP
Acurx Pharmaceuticals Inc
2.33+0.25+12.02%
SNSE
Sensei Biotherapeutics Inc
1.09+0.05+4.81%
BIVI
BioVie Inc
0.5336+0.0025+0.4707%
NGNE
Neurogene Inc
49.26-0.19-0.38%